Boston Scientific receives CE Marking for ALTRUA pacemakers
Boston Scientific Corp. was given European CE Marking for its new ALTRUA family of pacemakers. ALTRUA pacemakers are used to treat bradycardia, a condition in which the heart beats too slowly. ALTRUA is flexible and features a sensor to regulate the heart after experiencing physical activity or emotional stress and an automatic capture capability designed for automatic and accurate ventricular pulse management.
- Boston Scientific Announces European Approval and Launch of Platinum Chromium PROMUS(R) Element(TM) Stent System
- Boston Scientific receives FDA approval for stents
- Europe initiates implants of Cognis, Teligen
- Boston receives FDA approval for Taxus Liberte
